{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:56:58Z","timestamp":1790384218398,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81273169"],"award-info":[{"award-number":["81273169"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573218"],"award-info":[{"award-number":["81573218"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773514"],"award-info":[{"award-number":["81773514"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.intimp.2020.106948","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T17:23:42Z","timestamp":1599153822000},"page":"106948","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Calprotectin in spondyloarthritis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"88","author":[{"given":"Yubo","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dazhi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixiang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faming","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.intimp.2020.106948_b0005","doi-asserted-by":"crossref","first-page":"7706","DOI":"10.1016\/S0021-9258(20)89506-4","article-title":"Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells","volume":"266","author":"Edgeworth","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"6143","key":"10.1016\/j.intimp.2020.106948_b0010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/330080a0","article-title":"Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis","volume":"330","author":"Odink","year":"1987","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2020.106948_b0015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1189\/jlb.1008647","article-title":"The endogenous Toll-like receptor 4 agonist S100A8\/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer","volume":"86","author":"Ehrchen","year":"2009","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106948_b0020","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/rheumatology\/ket375","article-title":"TLR4 endogenous ligand MRP8\/14 level in enthesitis-related arthritis and its association with disease activity and TLR4 expression","volume":"53","author":"Rahman","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2020.106948_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2019.01.003","article-title":"Systemic calprotectin and chronic inflammatory rheumatic diseases","author":"Romand","year":"2019","journal-title":"Joint Bone Spine"},{"issue":"12","key":"10.1016\/j.intimp.2020.106948_b0030","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1136\/annrheumdis-2017-211695","article-title":"Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis","volume":"76","author":"Jonsson","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.intimp.2020.106948_b0035","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/ajg.2016.342","article-title":"Serum calprotectin: A novel diagnostic and prognostic marker in inflammatory bowel diseases","volume":"111","author":"Kalla","year":"2016","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.intimp.2020.106948_b0040","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1053\/j.gastro.2003.08.035","article-title":"Subclinical intestinal inflammation and sacroiliac changes in relatives of patients with ankylosing spondylitis","volume":"125","author":"Bjarnason","year":"2003","journal-title":"Gastroenterology"},{"issue":"13","key":"10.1016\/j.intimp.2020.106948_b0045","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1056\/NEJMc1609622","article-title":"Ankylosing spondylitis and axial spondyloarthritis","volume":"375","author":"Rudwaleit","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.intimp.2020.106948_b0050","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/annrheumdis-2012-202925","article-title":"Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation","volume":"73","author":"Ciccia","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.intimp.2020.106948_b0055","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.24763","article-title":"HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats","volume":"60","author":"DeLay","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.intimp.2020.106948_b0060","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ng.2667","article-title":"Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci","volume":"45","author":"Cortes","year":"2013","journal-title":"Nat. Genet."},{"issue":"suppl 2","key":"10.1016\/j.intimp.2020.106948_b0065","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kew349","article-title":"New treatment targets for axial spondyloarthritis","volume":"55","author":"Sieper","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.intimp.2020.106948_b0070","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1373\/clinchem.2007.099549","article-title":"Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis","volume":"54","author":"de Seny","year":"2008","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2020.106948_b0075","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/00365521.2011.648953","article-title":"Calprotectin in ankylosing spondylitis\u2013frequently elevated in feces, but normal in serum","volume":"47","author":"Klingberg","year":"2012","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.intimp.2020.106948_b0080","first-page":"1","article-title":"Serum calprotectin correlates with risk and disease severity of ankylosing spondylitis and its change during first month might predict favorable response to treatment","author":"Hu","year":"2018","journal-title":"Mod. Rheumatol."},{"issue":"9","key":"10.1016\/j.intimp.2020.106948_b0085","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1136\/annrheumdis-2014-205506","article-title":"Calprotectin serum level is an independent marker for radiographic spinal progression in axial spondyloarthritis","volume":"73","author":"Turina","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.intimp.2020.106948_b0090","first-page":"2089","article-title":"S100 proteins calprotectin and S100A12 are related to radiographic changes rather than disease activity in psoriatic arthritis with low disease activity","volume":"34","author":"Madland","year":"2007","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106948_b0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/03009742.2017.1299216","article-title":"Faecal calprotectin detects subclinical bowel inflammation and may predict treatment response in spondyloarthritis","volume":"47","author":"Ostgard","year":"2018","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.intimp.2020.106948_b0100","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kez025","article-title":"Added value of biomarkers compared with clinical parameters for the prediction of radiographic spinal progression in axial spondyloarthritis","author":"Rademacher","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.intimp.2020.106948_b0105","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/JIM.0000000000000095","article-title":"Elevated serum levels of calprotectin (myeloid-related protein 8\/14) in patients with ankylosing spondylitis and its association with disease activity and quality of life","volume":"62","author":"Oktayoglu","year":"2014","journal-title":"J. Invest. Med."},{"issue":"6","key":"10.1016\/j.intimp.2020.106948_b0110","doi-asserted-by":"crossref","first-page":"R261","DOI":"10.1186\/ar4106","article-title":"Markers of intestinal inflammation in patients with ankylosing spondylitis: a pilot study","volume":"14","author":"Matzkies","year":"2012","journal-title":"Arthritis Res Ther."},{"issue":"1","key":"10.1016\/j.intimp.2020.106948_b0115","doi-asserted-by":"crossref","first-page":"13728","DOI":"10.1038\/s41598-018-32199-3","article-title":"Association of circulating calprotectin with lipid profile in axial spondyloarthritis","volume":"8","author":"Genre","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.intimp.2020.106948_b0120","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int. J. Surg."},{"issue":"15","key":"10.1016\/j.intimp.2020.106948_b0125","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.intimp.2020.106948_b0130","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12931-019-1123-x","article-title":"Chronic obstructive pulmonary disease in rheumatoid arthritis: a systematic review and meta-analysis","volume":"20","author":"Ma","year":"2019","journal-title":"Respir. Res."},{"issue":"2","key":"10.1016\/j.intimp.2020.106948_b0135","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res. Synth Methods."},{"issue":"7414","key":"10.1016\/j.intimp.2020.106948_b0140","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Bmj."},{"issue":"7","key":"10.1016\/j.intimp.2020.106948_b0145","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/rheumatology\/key427","article-title":"Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis: results from the SPARTAKUS cohort","volume":"58","author":"Olofsson","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.intimp.2020.106948_b0150","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s13075-014-0413-4","article-title":"Calprotectin (S100A8\/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis","volume":"16","author":"Turina","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2020.106948_b0155","doi-asserted-by":"crossref","first-page":"7574147","DOI":"10.1155\/2017\/7574147","article-title":"Discriminating value of calprotectin in disease activity and progression of nonradiographic axial spondyloarthritis and ankylosing spondylitis","volume":"2017","author":"Huang","year":"2017","journal-title":"Dis. Markers"},{"issue":"12","key":"10.1016\/j.intimp.2020.106948_b0160","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1007\/s10067-016-3448-x","article-title":"Elevated levels of serum MRP8\/14 in ankylosing spondylitis: associated with peripheral arthritis and active disease","volume":"35","author":"Gupta","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.intimp.2020.106948_b0165","doi-asserted-by":"crossref","first-page":"696415","DOI":"10.1155\/2014\/696415","article-title":"S-calprotectin (S100A8\/S100A9): a potential marker of inflammation in patients with psoriatic arthritis","volume":"2014","author":"Hansson","year":"2014","journal-title":"J. Immunol. Res."},{"issue":"5","key":"10.1016\/j.intimp.2020.106948_b0170","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jaad.2010.02.049","article-title":"Markedly elevated serum levels of calcium-binding S100A8\/A9 proteins in psoriatic arthritis are due to activated monocytes\/macrophages","volume":"64","author":"Aochi","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"issue":"7","key":"10.1016\/j.intimp.2020.106948_b0175","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/acr.22795","article-title":"Serum calprotectin versus acute-phase reactants in the discrimination of inflammatory disease activity in rheumatoid arthritis patients receiving tumor necrosis factor inhibitors","volume":"68","author":"Inciarte-Mundo","year":"2016","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"1","key":"10.1016\/j.intimp.2020.106948_b0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13075-017-1223-2","article-title":"A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis","volume":"19","author":"Klingberg","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2020.106948_b0185","article-title":"Relationship between fecal calprotectin, anti-Saccharomyces cerevisiae antibodies and other markers of disease activity in patients with spondyloarthritis","author":"Moreno Martinez","year":"2018","journal-title":"Reumatol. Clin."},{"issue":"7","key":"10.1016\/j.intimp.2020.106948_b0190","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/annrheumdis-2015-208025","article-title":"Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis","volume":"75","author":"Cypers","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2020.106948_b0195","first-page":"71","article-title":"Fecal calprotectin is associated with disease activity in patients with ankylosing spondylitis","volume":"16","author":"Duran","year":"2016","journal-title":"Bosn J. Basic Med. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2020.106948_b0200","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.arcmed.2019.04.003","article-title":"Fecal calprotectin, gut inflammation and spondyloarthritis","volume":"50","author":"Simioni","year":"2019","journal-title":"Arch. Med. Res."},{"issue":"12","key":"10.1016\/j.intimp.2020.106948_b0205","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1136\/annrheumdis-2017-211695","article-title":"Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis","volume":"76","author":"Jonsson","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2020.106948_b0210","first-page":"429","article-title":"Serum calprotectin as a marker of ultrasound-detected synovitis in early psoriatic and rheumatoid arthritis: results from a cross-sectional retrospective study","volume":"37","author":"Sakellariou","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"issue":"5","key":"10.1016\/j.intimp.2020.106948_b0215","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/10408363.2019.1619159","article-title":"Clinical value of fecal calprotectin","volume":"56","author":"Ricciuto","year":"2019","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2020.106948_b0220","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/annrheumdis-2013-203582","article-title":"Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis","volume":"74","author":"Stolwijk","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2020.106948_b0225","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/00365521.2014.987809","article-title":"Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease","volume":"50","author":"Sipponen","year":"2015","journal-title":"Scand. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106948_b0230","first-page":"183","article-title":"The role of serum calprotectin as a novel biomarker in inflammatory bowel diseases: a review study","volume":"12","author":"Azramezani Kopi","year":"2019","journal-title":"Gastroenterol. Hepatol. Bed. Bench."},{"issue":"4","key":"10.1016\/j.intimp.2020.106948_b0235","first-page":"980","article-title":"Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis","volume":"26","author":"Spoorenberg","year":"1999","journal-title":"J. Rheumatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920319548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920319548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T23:01:14Z","timestamp":1744498874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920319548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":47,"alternative-id":["S1567576920319548"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106948","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calprotectin in spondyloarthritis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106948","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106948"}}